MiR-200a is involved in proliferation and apoptosis in the human endometrial adenocarcinoma cell line HEC-1B by targeting the tumor suppressor PTEN

Molecular Biology Reports

Volumn 41, Issue 4, 2014, Pages 1977-1984

  Li, Rong ^a,b   He, Jun Lin ^a   Chen, Xue Mei ^a   Long, Chun Lan ^c   Yang, De Hui ^a   Ding, Yu Bin ^a,b   Qi, Hong Bo ^b   Liu, Xue Qing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; HEC 1B; miR 200a; Proliferation; PTEN

Indexed keywords

MESSENGER RNA; MICRORNA 200A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN; 3' UNTRANSLATED REGION; MICRORNA; MIRN200 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CULTURE; CELL PROLIFERATION; CHROMOSOME DELETION; DOWN REGULATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ADENOCARCINOMA; BASE PAIRING; CELL CYCLE; CHEMISTRY; ENDOMETRIUM TUMOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; NUCLEOTIDE SEQUENCE; RNA INTERFERENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADENOCARCINOMA; APOPTOSIS; BASE PAIRING; BASE SEQUENCE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE; RNA, MESSENGER; TRANSFECTION;

EID: 84897487596     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3045-5     Document Type: Article

References (37)

1. Ray M, Fleming G (2009) Management of advanced-stage and recurrent endometrial cancer. Semin Oncol 36:145-154
2. Okuda T, Sekizawa A, Purwosunu Y, Nagatsuka M, Morioka M, Hayashi M, Okai T (2010) Genetics of endometrial cancers. Obstet Gynecol Int 2010:984013
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71-96 (Pubitemid 351521864)
4. Lee DY, Jeyapalan Z, Fang L, Yang J, Zhang Y, Yee AY, Li M, Du WW, Shatseva T, Yang BB (2010) Expression of versican 3′-untranslated region modulates endogenous microRNA functions. PLoS One 5:e13599
5. Stark A, Brennecke J, Bushati N, Russell RB, Cohen SM (2005) Animal MicroRNAs confer robustness to gene expression and have a significant impact on 3′UTR evolution. Cell 123:1133-1146 (Pubitemid 41785426)
6. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297 (Pubitemid 38167318)
7. Tricoli JV, Jacobson JW (2007) MicroRNA: potential for cancer detection, diagnosis, and prognosis. Cancer Res 67:4553-4555 (Pubitemid 46910157)
8. Negrini M, Ferracin M, Sabbioni S, Croce CM (2007) MicroRNAs in human cancer: from research to therapy. J Cell Sci 120:1833-1840 (Pubitemid 46979774)
9. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, Jacob ST, Ghoshal K (2006) Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 99:671-678 (Pubitemid 44521987)
10. Gaur A, Jewell DA, Liang Y, Ridzon D, Moore JH, Chen C, Ambros VR, Israel MA (2007) Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res 67:2456-2468 (Pubitemid 46548930)
11. Croce CM, Calin GA (2005) miRNAs, cancer, and stem cell division. Cell 122:6-7 (Pubitemid 40977933)
12. Wu X, Zhao B, Li W, Chen Y, Liang R, Li L, Jin Y, Ruan K (2012) MiR-200a is involved in rat epididymal development by targeting beta-catenin mRNA. Acta Biochim Biophys Sin (Shanghai) 44:233-240
13. Soubani O, Ali AS, Logna F, Ali S, Philip PA, Sarkar FH (2013) Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis 33:1563-1571
14. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O, Nicolas A, Meyniel JP, Cottu P, Sastre-Garau X, Mechta-Grigoriou F (2011) miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 17:1627-1635
15. Eades G, Yang M, Yao Y, Zhang Y, Zhou Q (2011) miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 286:40725-40733
16. Li A, Omura N, Hong SM, Vincent A, Walter K, Griffith M, Borges M, Goggins M (2010) Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels. Cancer Res 70:5226-5237
17. Pan Q, Chegini N (2008) MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med 26:479-493
18. Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S, Lam EW (2010) Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer. Cancer Res 70:367-377
19. Lee JW, Park YA, Choi JJ, Lee YY, Kim CJ, Choi C, Kim TJ, Lee NW, Kim BG, Bae DS (2011) The expression of the miRNA-200 family in endometrial endometrioid carcinoma. Gynecol Oncol 120:56-62
20. Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H, Yaegashi N (2010) Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 101:241-249
21. Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R (2013) Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients. Int J Cancer 132:1633-1645
22. Qian K, Chen H, Wei Y, Hu J, Zhu G (2005) Differentiation of endometrial stromal cells in vitro: down-regulation of suppression of the cell cycle inhibitor p57 by HOXA10? Mol Hum Reprod 11:245-251 (Pubitemid 40662809)
23. Schmittgen TD, Jiang J, Liu Q, Yang L (2004) A high-throughput method to monitor the expression of microRNA precursors. Nucleic Acids Res 32:e43
24. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG (2007) miRGen: A database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 35:D149-D155 (Pubitemid 46056188)
25. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20 (Pubitemid 40094598)
26. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N (2005) Combinatorial microRNA target predictions. Nat Genet 37:495-500 (Pubitemid 40617277)
27. Osborne C, Wilson P, Tripathy D (2004) Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist 9:361-377 (Pubitemid 39014548)
28. Croce CM (2008) Oncogenes and cancer. N Engl J Med 358:502-511 (Pubitemid 351185806)
29. Leslie NR, Foti M (2011) Non-genomic loss of PTEN function in cancer: not in my genes. Trends Pharmacol Sci 32:131-140
30. Yu J, Ryan DG, Getsios S, Oliveira-Fernandes M, Fatima A, Lavker RM (2008) MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci USA 105:19300-19305
31. Zbuk KM, Eng C (2007) Cancer phenomics: RET and PTEN as illustrative models. Nat Rev Cancer 7:35-45 (Pubitemid 46020845)
32. Yan X, Fraser M, Qiu Q, Tsang BK (2006) Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner. Gynecol Oncol 102:348-355 (Pubitemid 44063583)
33. Wang X, Trotman LC, Koppie T, Alimonti A, Chen Z, Gao Z, Wang J, Erdjument-Bromage H, Tempst P, Cordon-Cardo C, Pandolfi PP, Jiang X (2007) NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128:129-139 (Pubitemid 46048884)
34. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, Yang H, Pavletich NP, Carver BS, Cordon-Cardo C, Erdjument-Bromage H, Tempst P, Chi SG, Kim HJ, Misteli T, Jiang X, Pandolfi PP (2007) Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128:141-156 (Pubitemid 46048885)
35. Schondorf T, Ebert MP, Hoffmann J, Becker M, Moser N, Pur S, Gohring UJ, Weisshaar MP (2004) Hypermethylation of the PTEN gene in ovarian cancer cell lines. Cancer Lett 207:215-220 (Pubitemid 38457043)
36. Blumenthal GM, Dennis PA (2008) PTEN hamartoma tumor syndromes. Eur J Hum Genet 16:1289-1300
37. Salmena L, Carracedo A, Pandolfi PP (2008) Tenets of PTEN tumor suppression. Cell 133:403-414 (Pubitemid 351622014)